4.6 Review

Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

Journal

ENDOCRINE REVIEWS
Volume 36, Issue 6, Pages 593-602

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/er.2015-1093

Keywords

-

Funding

  1. National Institutes of Health (NIH) [ES023254, ES020662]
  2. NIH [ES019178, ES02207, ES020886, CA172220, ES010026, ES020908]
  3. Ministerio de Economia y Competitividad [BFU2011-28358, SAF2014-58335-P]
  4. Generalitat Valenciana [PROMETEO/2011/080, PROMETEO/2015/016]
  5. Academy of Finland
  6. EU FP7 Environment and Quality of Life
  7. Sigrid Juselius Foundation
  8. Turku University Hospital Special Research Fund

Ask authors/readers for more resources

This Executive Summary to the Endocrine Society's second Scientific Statement on environmental endocrine-disrupting chemicals (EDCs) provides a synthesis of the key points of the complete statement. The full Scientific Statement represents a comprehensive review of the literature on seven topics for which there is strong mechanistic, experimental, animal, and epidemiological evidence for endocrine disruption, namely: obesity and diabetes, female reproduction, male reproduction, hormone-sensitive cancers in females, prostate cancer, thyroid, and neurodevelopment and neuroendocrine systems. EDCs such as bisphenol A, phthalates, pesticides, persistent organic pollutants such as polychlorinated biphenyls, polybrominated diethyl ethers, and dioxins were emphasized because these chemicals had the greatest depth and breadth of available information. The Statement also included thorough coverage of studies of developmental exposures to EDCs, especially in the fetus and infant, because these are critical life stages during which perturbations of hormones can increase the probability of a disease or dysfunction later in life. A conclusion of the Statement is that publications over the past 5 years have led to a much fuller understanding of the endocrine principles by which EDCs act, including nonmonotonic dose-responses, low-dose effects, and developmental vulnerability. These findings will prove useful to researchers, physicians, and other healthcare providers in translating the science of endocrine disruption to improved public health. (Endocrine Reviews 36: 593-602, 2015)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available